Cognitive Disorders and Delirium (PDQ®)
Topics in This Section
- Causes of Cognitive Disorders and Delirium
- Effects of Cognitive Disorders and Delirium on the Patient, Family, and Health Care Providers
- Diagnosis of Cognitive Disorders and Delirium
- Treatment of Delirium
- Treatment of the Symptoms of Delirium by Changing the Patient's Surroundings
- Treatment of the Causes of Delirium
- Treatment of the Symptoms of Delirium with Medication
- Delirium and Sedation
- Current Clinical Trials
- Changes to This Summary (08/19/2011)
- Questions or Comments About This Summary
- Get More Information From NCI
- About PDQ
Cognitive disorders and delirium are conditions in which the patient experiences a confused mental state and changes in behavior.
People who have cognitive disorders or delirium may fall in and out of consciousness and may have problems with the following:
- Muscle control.
- Sleeping and waking.
Delirium occurs frequently in patients with cancer, especially in patients with advanced cancer.
Delirium usually occurs suddenly and the patient's symptoms may come and go during the day. This condition can be treated and is often temporary, even in people with advanced illness. In the last 24 to 48 hours of life, however, delirium may be permanent due to problems such as organ failure.
This summary is about cognitive disorders in adults with cancer.
Cognitive disorders and delirium may be complications of cancer and cancer treatment, especially in people with advanced cancer.
In patients with cancer, cognitive disorders and delirium may be due to the direct effects that cancer has on the brain, such as the pressure of a growing tumor. Cognitive disorders and delirium may also be caused by indirect effects of cancer or its treatment, including the following:
- Organ failure.
- Electrolyte imbalances: Electrolytes are important minerals (including salt, potassium, calcium, and phosphorous) that are needed to keep the heart, kidneys, nerves, and muscles working correctly.
- Symptoms caused by the cancer but that occur apart from the local or distant spread of the tumor (paraneoplastic syndromes), such as inflammation of the brain.
- Medication side effects: Patients with cancer usually take many medications. Some drugs have side effects that include delirium and confusion. The effects of these drugs usually go away after the drug is stopped.
- Withdrawal from drugs that depress (slow down) the central nervous system (brain and spinal cord).
Risk factors for delirium include having a serious disease and having more than one disease.
Other conditions besides having cancer may place a patient at risk for developing delirium. Risk factors include the following:
- Advanced cancer or other serious illness.
- Having more than one disease.
- Older age.
- Previous mental disorder, such as dementia.
- Low levels of albumin (protein) in the blood.
- Taking medications that affect the mind or behavior.
- Taking high doses of pain medication.
Early identification of risk factors may help prevent the onset of delirium or may reduce the length of time it takes to correct it.
Cognitive disorders and delirium can be upsetting to the patient's family and caregivers.
Cognitive disorders and delirium can be upsetting to the family and caregivers, and may be dangerous to the patient if judgment is affected. These conditions can cause the patient to act unpredictably and sometimes violently. Even a quiet or calm patient can suddenly experience a change in mood or become agitated, requiring increased care. The safety of the patient, family, and caregivers is most important.
Cognitive disorders and delirium may affect physical health and communication.
Patients with cognitive disorders or delirium are more likely to fall, be incontinent (unable to control bladder and/or bowels), and become dehydrated (drink too little water to maintain health). They often require a longer hospital stay than patients without cognitive disorders or delirium.
The confused mental state of these patients may hinder their communication with family members and the health care providers. Assessment of the patient's symptoms becomes difficult and the patient may be unable to make decisions regarding care. Agitation in these patients may be mistaken as an expression of pain. Conflict can arise among the patient, family, and staff concerning the level of pain medication needed.
Possible signs of cognitive disorders and delirium include sudden personality changes, impaired thinking, or unusual anxiety or depression.
A patient who suddenly becomes agitated or uncooperative, experiences personality or behavior changes, has impaired thinking, decreased attention span, or intense, unusual anxiety or depression, may be experiencing cognitive disorders or delirium. Patients who develop these symptoms need to be assessed completely.
The symptoms of delirium are similar to symptoms of depression and dementia.
Early symptoms of delirium are similar to symptoms of anxiety, anger, depression, and dementia. Delirium that causes the patient to be very inactive may appear to be depression. Delirium and dementia are difficult to tell apart, since both may cause disorientation and impair memory, thinking, and judgment. Dementia may be caused by a number of medical conditions, including Alzheimer disease. Some differences in the symptoms of delirium and dementia include the following:
- Patients with delirium often go in and out of consciousness. Patients who have dementia usually remain alert.
- Delirium may occur suddenly. Dementia appears gradually and gets worse over time.
- Sleeping and waking problems are more common with delirium than with dementia.
In elderly patients who have cancer, dementia is often present along with delirium, making diagnosis difficult. The diagnosis is more likely dementia if symptoms continue after treatment for delirium is given.
In patients aged 65 or older who have survived cancer for more than 5 years, the risk for cognitive disorders and dementia is increased, apart from the risk for delirium.
Regular screening of the patient and monitoring of the patient's symptoms can help in the diagnosis of delirium.
Patient and family concerns are addressed when deciding the treatment of delirium. Deciding if, when, and how to treat a person with delirium depends on the setting, how advanced the cancer is, the wishes of the patient and family, and how the delirium symptoms are affecting the patient.
Monitoring alone may be all that is necessary for patients who are not dangerous to themselves. In other cases, symptoms may be treated or causes of the delirium may be identified and treated.
Controlling the patient's surroundings may help reduce mild symptoms of delirium. The following changes may be effective:
- Putting the patient in a quiet, well-lit room with familiar objects.
- Placing a clock or calendar where the patient can see it.
- Reducing noise.
- Having family present.
- Limiting changes in caregivers.
To prevent a patient from harming himself or herself or others, physical restraints also may be necessary.
The standard approach to managing delirium is to find and treat the causes. Symptoms may be treated at the same time. Identifying the causes of delirium will include a physical examination to check general signs of health, including checking for signs of disease. A medical history of the patient’s past illnesses and treatments will also be taken. In a terminally ill delirious patient being cared for at home, the doctor may do a limited assessment to determine the cause or may treat just the symptoms.
Treatment may include the following:
- Stopping or reducing medications that cause delirium.
- Giving fluids into the bloodstream to correct dehydration.
- Giving drugs to correct hypercalcemia (too much calcium in the blood).
- Giving antibiotics for infections.
Drugs called antipsychotics may be used to treat the symptoms of delirium. Drugs that sedate (calm) the patient may also be used, especially if the patient is near death. All of these drugs have side effects and the patient will be monitored closely by a doctor. The decision to use drugs that sedate the patient will be made in cooperation with family members after efforts have been made to reverse the delirium.
The decision to use drugs to sedate the patient who is near death and has symptoms of delirium, pain, and difficult breathing presents ethical and legal issues for both the doctor and the family. When the symptoms of delirium are not relieved with standard treatment approaches and the patient is experiencing severe distress and suffering, the doctor may discuss the option to give drugs that will sedate the patient. This decision is guided by the following principles:
- Health care professionals who have experience in palliative care make repeated assessments of the patient’s response to treatments. The family is always included.
- The need to use drugs that sedate the patient is evaluated by a multidisciplinary team of health care professionals.
- Temporary sedation should be considered.
- A multidisciplinary team of health care professionals will work with the family to ensure that the family's views are assessed and understood. The family may need support from the health care team and mental health professionals while palliative sedation is used.
Check NCI’s list of cancer clinical trials for U.S. supportive and palliative care trials about cognitive/functional effects that are now accepting participants. The list of trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Editorial changes were made to this summary.
If you have questions or comments about this summary, please send them to Cancer.gov through the Web site’s Contact Form. We can respond only to email messages written in English.
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.
The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
Write to us
For more information from the NCI, please write to this address:
- NCI Public Inquiries Office
- Suite 3036A
- 6116 Executive Boulevard, MSC8322
- Bethesda, MD 20892-8322
Search the NCI Web site
The NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families. For a quick search, use the search box in the upper right corner of each Web page. The results for a wide range of search terms will include a list of "Best Bets," editorially chosen Web pages that are most closely related to the search term entered.
There are also many other places to get materials and information about cancer treatment and services. Hospitals in your area may have information about local and regional agencies that have information on finances, getting to and from treatment, receiving care at home, and dealing with problems related to cancer treatment.
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237).
PDQ is a comprehensive cancer database available on NCI's Web site.
PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ is available online at NCI's Web site. PDQ is provided as a service of the NCI. The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research.
PDQ contains cancer information summaries.
The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries are available in two versions. The health professional versions provide detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions provide current and accurate cancer information.
Images in the PDQ summaries are used with permission of the author(s), artist, and/or publisher for use within the PDQ summaries only. Permission to use images outside the context of PDQ information must be obtained from the owner(s) and cannot be granted by the National Cancer Institute. Information about using the illustrations in the PDQ summaries, along with many other cancer-related images, are available in Visuals Online, a collection of over 2,000 scientific images.
The PDQ cancer information summaries are developed by cancer experts and reviewed regularly.
Editorial Boards made up of experts in oncology and related specialties are responsible for writing and maintaining the cancer information summaries. The summaries are reviewed regularly and changes are made as new information becomes available. The date on each summary ("Date Last Modified") indicates the time of the most recent change.
PDQ also contains information on clinical trials.
A clinical trial is a study to answer a scientific question, such as whether one method of treating symptoms is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. Some patients have symptoms caused by cancer treatment or by the cancer itself. During supportive care clinical trials, information is collected about how well new ways to treat symptoms of cancer work. The trials also study side effects of treatment and problems that come up during or after treatment. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients who have symptoms related to cancer treatment may want to think about taking part in a clinical trial.
Listings of clinical trials are included in PDQ and are available online at NCI's Web site. Descriptions of the trials are available in health professional and patient versions. Many cancer doctors who take part in clinical trials are also listed in PDQ. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).